此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Milk Supplementation and Bone Health in Children

2021年9月29日 更新者:Yu-ming Chen、Sun Yat-sen University

Effects of Yili Child Formula Milk on Bone Health in 4-6 Year Children: a 12-month Randomized Controlled Trial

Objectives: to examine the effects of a Yili child formula milk and regular milk on bone health and growth in young children.

Study design: cluster randomized controlled trial.

Setting: kindergartens in Hui-ning County of Gansu Province, China (north west).

Participants: >=246 apparent healthy children aged 4-6 years old.

Interventions:

(I) Yili child formula milk (QQ star formula, SCI-PRO NUTR5+6TM), 195 ml *2 /day; (II) Yili regular milk (pure milk), 195ml*2 /day; (III) Controls: about 50g/d grain foods (containing 20-30 g carbohydrates), e.g. bread.

Interventional Duration: 12 months.

Outcome measures: determined at 0, 6 and 12 months post treatments. Primary outcomes: bone density and bone mineral contents at the forearm and heel, bone biomarkers.

Secondary outcomes: (1) anthropometric indices: weight, height, waist circumference, etc.; (2) immune status.

Other measures: dietary intakes, physical activities, general information, medical information, adverse of side effects.

Data Analyses: The one-year changes and percent changes in the primary and secondary outcomes will be compared among the 3 groups.

研究概览

研究类型

介入性

注册 (预期的)

254

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • Gangshu
      • Lanzhou、Gangshu、中国、730000
        • LanZhou University

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

4年 至 6年 (孩子)

接受健康志愿者

是的

有资格学习的性别

全部

描述

Inclusion Criteria:

  • Aged between 4-6 years;
  • female and male
  • Can be enrolled into kindergarten/school as a normal child.
  • Be willing to drinking milk daily.

Exclusion Criteria:

  • Milk allergy or intolerance, did not to be used to drinking milk;
  • Had the following diseases/conditions confirmed by a hospital: serious diseases of heart, liver, kidney, brain, hematopoietic system, immunity, thyroid or cancer that need to be hospitalization for more than 1 week or take medication(s) for more than 1 month with the past two years.
  • having infectious diseases, e.g., tuberculosis, hepatitis, etc.
  • Taking vitamin D, calcium tables or nutrient package;
  • Consumed more than 3 times (>600ml) milk each week in the previous month.
  • Be not willing to provide informed consent, or have other conditions that were considered to be unsuitable for the study by the investigators.
  • Increases of body health were out of the range between 5-8 cm in the last year.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:预防
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:单身的

武器和干预

参与者组/臂
干预/治疗
实验性的:Formula Milk

Formula milk designed for young children aged over 3 years;

Dosage: 195 ml/time;

Frequence: 2 times /day;

Duration: 12 months

Brand name: Yili (QQ star formula milk);

Type: SCI-PRO NUTRI 5+6TM formula milk designed for young children aged over 3 years;

Dosage: 195ml*2/d;

Intervention duration: 12 months

有源比较器:Regular milk

Regular milk (pure milk);

Dosage: 195 ml/time;

Frequence: 2 times /day;

Duration: 12 months

Brand name: Yili;

Type: regular milk (pure milk);

Dosage: 195ml*2/d;

Intervention duration: 12 months

其他:Control foods

Grain foods: e.g., bread;

Dosage: 20-40 g/time;

Frequence: 2 times /day;

Duration: 12 months

Brand: N/A;

Food type: grain foods (e.g., bread);

Dosage: 20-40g * 2/d grain foods

Intervention duration: 12 months

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Change from baseline bone mineral density (BMD) at 12 months
大体时间:0 and 12 months
BMD (g/cm2) determined by a dual energy x-ray absorptiometry (DXA) at the left forearm and heel
0 and 12 months
Change from baseline bone mineral density (BMD) at 6 months
大体时间:0 and 6 months
BMD (g/cm2) determined by DXA at the left forearm and heel
0 and 6 months
Change from baseline bone mineral contents (BMC) at 12 months
大体时间:0 and 12 months
BMC (g) determined by DXA at the left forearm and heel.
0 and 12 months
Change from baseline bone mineral contents (BMC) at 6 months
大体时间:0 and 6 months
BMC (g) determined by DXA at the left forearm and heel.
0 and 6 months
Change from baseline of bone-specific alkaline phosphatase at 12 months
大体时间:0 and 12 months
Bone turnover marker 1: Bone-specific alkaline phosphatase
0 and 12 months
Change from baseline of bone-specific alkaline phosphatase at 6 months
大体时间:0 and 6 months
Bone turnover marker 1: Bone-specific alkaline phosphatase
0 and 6 months
Change from baseline of osteocalcin at 12 months
大体时间:0 and 12 months
Bone turnover marker 2: osteocalcin
0 and 12 months
Change from baseline of osteocalcin at 6 months
大体时间:0 and 6 months
Bone turnover marker 2: osteocalcin
0 and 6 months
Change from baseline of C-terminal telopeptide of type I collagen at 12 months
大体时间:0 and 12 months
Bone turnover marker 3: C-terminal telopeptide of type I collagen
0 and 12 months
Change from baseline of C-terminal telopeptide of type I collagen at 6 months
大体时间:0 and 6 months
Bone turnover marker 3: C-terminal telopeptide of type I collagen
0 and 6 months
Change from baseline of tartrate resistant acid phosphatase at 12 months
大体时间:0 and 12 months
Bone turnover marker 4: tartrate resistant acid phosphatase
0 and 12 months
Change from baseline of tartrate resistant acid phosphatase at 6 months
大体时间:0 and 6 months
Bone turnover marker 4: tartrate resistant acid phosphatase
0 and 6 months

次要结果测量

结果测量
措施说明
大体时间
Change from baseline body weight at 12 months
大体时间:0 and 12 months
Anthropometric indices: body weight
0 and 12 months
Change from baseline body height at 12 months
大体时间:0 and 12 months
Anthropometric indices: body height
0 and 12 months
Change from baseline biomarker of body growth at 12 months
大体时间:0 and 12 months
Biomarker of body growth: insulin-like growth factor 1
0 and 12 months
Change from baseline immune globulin M (Ig M)at 12 months
大体时间:0 and 12 months
Immune status: Blood Ig M
0 and 12 months
Change from baseline immune globulin G (Ig G)at 12 months
大体时间:0 and 12 months
Immune status: Blood Ig G
0 and 12 months
Change from baseline immune globulin G (Ig A)at 12 months
大体时间:0 and 12 months
Immune status: Blood Ig A
0 and 12 months
Change from baseline whit blood cell at 12 months
大体时间:0 and 12 months
Immune status: whit blood cell
0 and 12 months

其他结果措施

结果测量
措施说明
大体时间
Concentrations of blood total 25-hydroxide-vitamin D (25-OH-VD)
大体时间:0, 6 and 12 months
Serum 25-OH-VD
0, 6 and 12 months
Concentrations of blood parathyroid Hormone (PTH)
大体时间:0, 6 and 12 months
Serum PTH
0, 6 and 12 months
Nutritional status 1: Body weight
大体时间:0, 4, 8 and 12 months
Body weight (in kg)
0, 4, 8 and 12 months
Nutritional status 2: waist circumference
大体时间:0, 4, 8 and 12 months
Waist circumference (in cm)
0, 4, 8 and 12 months
Nutritional status 3: middle-arm circumference
大体时间:0, 4, 8 and 12 months
Middle-arm circumference (in cm)
0, 4, 8 and 12 months
Nutritional status 4: skinfold thickness
大体时间:0, 4, 8 and 12 months
Skinfold thickness (in mm)
0, 4, 8 and 12 months
Total consumption of milk and dairy food
大体时间:0, 4, 8 and 12 months
Total consumption of milk and dairy food (in ml/d)
0, 4, 8 and 12 months
Consumption of dietary energy
大体时间:0, 4, 8 and 12 months
Consumption of dietary energy (in kcal/d)
0, 4, 8 and 12 months
Consumption of dietary protein
大体时间:0, 4, 8 and 12 months
Consumption of dietary protein (in g/d)
0, 4, 8 and 12 months
Consumption of dietary calcium
大体时间:0, 4, 8 and 12 months
Consumption of dietary calcium (in mg/d)
0, 4, 8 and 12 months
Number of participants with treatment-related adverse events
大体时间:0, 4, 8 and 12 months
Adverse events : assessed by using questionnaires of medical conditions, medications related to milk intake
0, 4, 8 and 12 months
Child behaviors
大体时间:0 and 12 months
Child behaviours: assessed by using a Child behavior Questionnaire-- parent version. The minimum and maximum values: 26-78; higher scores mean worse outcome.
0 and 12 months
Physical activity
大体时间:0, 4, 8 and 12 months
Physical activity (in MET, h/week): assessed by a Child Physical Activity Questionnaire
0, 4, 8 and 12 months
Concentrations of serum calcium
大体时间:0, 6 and 12 months
Serum calcium (mmol/L)
0, 6 and 12 months

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

合作者

调查人员

  • 首席研究员:Yuming Chen, Ph.D.、Sun Yat-sen University
  • 学习椅:Zhifu Zhao, M. Phil、Inner Mongolia Dairy Technology Research Institute Co., Ltd.

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2021年9月3日

初级完成 (预期的)

2022年10月30日

研究完成 (预期的)

2022年12月30日

研究注册日期

首次提交

2021年9月10日

首先提交符合 QC 标准的

2021年9月29日

首次发布 (实际的)

2021年10月12日

研究记录更新

最后更新发布 (实际的)

2021年10月12日

上次提交的符合 QC 标准的更新

2021年9月29日

最后验证

2021年9月1日

更多信息

与本研究相关的术语

其他研究编号

  • SYSU-51000-20210723-0001

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

IPD 计划说明

Published data based on reasonable request.

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅